Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation.

The article discusses a clinical study that was conducted to examine the association between the use of the drug clopidogrel after patients received either a drug-eluting stent or a bare-metal stent for the treatment of coronary artery disease. Clopidogrel is a drug used in thienopyridine antiplatelet therapy to prevent late stent thrombosis. The authors were interested in the long-term outcomes of patients and found that the use of clopidogrel in patients with drug-eluting stents may be associated with a lower risk of death or myocardial infarction.